---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-22-007235"
form_type: "8-K"
ticker: "LAB"
cik: "0001162194"
company_name: "STANDARD BIOTOOLS INC."
filed_at: "2022-11-08T23:59:59+00:00"
generated_at: "2026-06-22T02:56:12.879602+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Standard BioTools Q3 core revenue up 30% sequentially to $24.8M; GAAP net loss $29.4M

## Summary
- Core product/services revenue $24.8M, +30% sequentially; total revenue $25.6M, down from $28.5M YoY.
- GAAP net loss $29.4M vs $13.8M in Q3 2021; non-GAAP net loss $20.8M vs $5.4M.
- Cash, equivalents & short-term investments $185.2M at Sept 30, down from $211.2M at June 30.
- First restructuring phase saves $8M annually; reiterates 65-68% non-GAAP gross margin goal by end of 2023.
- Aiming for positive free cash flow by year-end 2024; launched X9 Real-Time PCR System.

## SEC filing metadata
- accession: 0001171843-22-007235
- form_type: 8-K
- ticker: LAB
- cik: 0001162194
- company_name: STANDARD BIOTOOLS INC.
- filed_at: 2022-11-08T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1162194/000117184322007235/0001171843-22-007235-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1162194/000117184322007235/f8k_110822.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-22-007235
- JSON: https://secwatch.observer/filing/0001171843-22-007235.json
- Plain text: https://secwatch.observer/filing/0001171843-22-007235.txt

## Key facts
- Earnings Releases
  STANDARD BIOTOOLS INC. reported financial results for third quarter ended September 30, 2022.
  - Period: third quarter ended September 30, 2022
  - Result: reported results
  source text: On November 8, 2022, Standard BioTools Inc. (the “Company”) issued a press release reporting its financial results for the third fiscal quarter of 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1162194/000117184322007235/0001171843-22-007235-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.